AIP
CRBP icon

Ameritas Investment Partners’s Corbus Pharmaceuticals CRBP Stock Holding History

Ameritas Investment Partners’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-996
Closed -$5.29K – 3230
2025
Q1 		$5.29K Hold
996
– – ﹤0.01% 2960
2024
Q4 		$11.8K Hold
996
– – ﹤0.01% 2858
2024
Q3 		$20.5K Hold
996
– – ﹤0.01% 2645
2024
Q2 		$45.1K Buy
+996
New +$41.9K ﹤0.01% 2199
2021
Q2 		– Sell
-167
Closed -$10K – 3092
2021
Q1 		$10K Hold
167
– – ﹤0.01% 2856
2020
Q4 		$6K Hold
167
– – ﹤0.01% 2933
2020
Q3 		$9K Hold
167
– – ﹤0.01% 2756
2020
Q2 		$42K Hold
167
– – ﹤0.01% 1935
2020
Q1 		$26K Buy
167
+37
+28% +$6.25K ﹤0.01% 2027
2019
Q4 		$21K Hold
130
– – ﹤0.01% 2385
2019
Q3 		$19K Hold
130
– – ﹤0.01% 2413
2019
Q2 		$27K Hold
130
– – ﹤0.01% 2262
2019
Q1 		$27K Hold
130
– – ﹤0.01% 2219
2018
Q4 		$23K Hold
130
– – ﹤0.01% 2257
2018
Q3 		$29K Hold
130
– – ﹤0.01% 2304
2018
Q2 		$20K Hold
130
– – ﹤0.01% 2507
2018
Q1 		$24K Hold
130
– – ﹤0.01% 2320
2017
Q4 		$28K Hold
130
– – ﹤0.01% 2263
2017
Q3 		$30K Hold
130
– – ﹤0.01% 2185
2017
Q2 		$24K Buy
+130
New +$25.5K ﹤0.01% 2353

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Ameritas Investment Partners's CRBP Position: Q2 2025 in Review

Ameritas Investment Partners sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 996 shares — an estimated $5.29K sold.

Ameritas Investment Partners first reported a position in CRBP in Q2 2017 and held it in 20 quarters. The position peaked at $45.1K in Q2 2024. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Ameritas Investment Partners reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 996 Corbus Pharmaceuticals shares in Q2 2025, an estimated $5.29K.
  • Ameritas Investment Partners first reported a position in Corbus Pharmaceuticals in Q2 2017 and held it in 20 quarters.
  • Ameritas Investment Partners's Corbus Pharmaceuticals position peaked at $45.1K in Q2 2024.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.